Cargando…

GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma

BACKGROUND: Tumor microenvironment (TME) plays a vital role in the development of hepatocellular carcinoma (HCC). Mounting evidence indicates that peripheral nerves could induce a shift from quiescent hepatic stellate cells (HSCs) to cancer-associated fibroblasts (CAFs) by secreting substance P (SP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanying, Wu, Jingliang, Lu, Qiao, Liu, Xuemin, Wen, Jiaxuan, Qi, Xiaohui, Liu, Jianhao, Lian, Bo, Zhang, Bo, Sun, Hengyi, Tian, Guixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188407/ https://www.ncbi.nlm.nih.gov/pubmed/35698562 http://dx.doi.org/10.2147/IJN.S366180

Ejemplares similares

GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor cells
por: Wu, Jingliang, et al.
Publicado: (2022)

Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
por: Lian, Bo, et al.
Publicado: (2021)

Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis
por: Wang, Fangqing, et al.
Publicado: (2021)

Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus(®)
por: Liu, Jinwen, et al.
Publicado: (2015)

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
por: Li, Zhaohuan, et al.
Publicado: (2021)

Improving the Stability of Liposomal Curcumin by Adjusting the Inner Aqueous Chamber pH of Liposomes
por: Wei, Xue-Qin, et al.
Publicado: (2020)

Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation
por: Cao, Xueyan, et al.
Publicado: (2023)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

Preparation and Characterization of Aprepitant Solid Dispersion with HPMCAS-LF
por: Liu, Jinwen, et al.
Publicado: (2022)

Preparation and in vivo evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex
por: Li, Yan, et al.
Publicado: (2023)

Liposomal curcumin and its application in cancer
por: Feng, Ting, et al.
Publicado: (2017)

Treatment for Refractory Pruritus Using Oral Aprepitant
por: Huh, Joon Won, et al.
Publicado: (2016)

Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016)

Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
por: Parvataneni, Swetha, et al.
Publicado: (2019)

The efficacy of aprepitant for the prevention of postoperative nausea and vomiting: A meta-analysis
por: Liu, Yingchao, et al.
Publicado: (2023)

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
por: Jin, Yilan, et al.
Publicado: (2021)

A pH‑responsive hyaluronic acid nano‑vehicle co‑encapsulating doxorubicin and all‑trans retinoic acid for the inhibition of hepatic stellate cell‑induced tumor growth and metastasis
por: Lu, Qiao, et al.
Publicado: (2023)

The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal Curcumin
por: Hocking, Ashleigh, et al.
Publicado: (2020)

Liposomal Curcumin is Better than Curcumin to Alleviate Complications in Experimental Diabetic Mellitus
por: Bulboacă, Adriana Elena, et al.
Publicado: (2019)

Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant
por: Olver, Ian, et al.
Publicado: (2007)

Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process
por: Kalvakuntla, Sunethra, et al.
Publicado: (2016)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
por: Kura, Raghunandan Reddy, et al.
Publicado: (2018)

Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects
por: Yang, Meng-Jie, et al.
Publicado: (2020)

Effectiveness of aprepitant in post‐acute COVID19 syndrome
por: Reinoso‐Arija, Rocío, et al.
Publicado: (2021)

Preparation of Curcumin-Loaded Liposomes and Evaluation of Their Skin Permeation and Pharmacodynamics
por: Chen, Yan, et al.
Publicado: (2012)

Functional liposome loaded curcumin for the treatment of Streptococcus mutans biofilm
por: Hu, Zhimin, et al.
Publicado: (2023)

HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma
por: Zhang, Xiangxiang, et al.
Publicado: (2022)

Research on Cartilage 3D Printing Technology Based on SA-GA-HA
por: Chen, Yong, et al.
Publicado: (2023)

Differential expression and regulation of prohibitin during curcumin-induced apoptosis of immortalized human epidermal HaCaT cells
por: YANG, HAI-BO, et al.
Publicado: (2014)

Curcumin-Loaded Platelet Membrane Bioinspired Chitosan-Modified Liposome for Effective Cancer Therapy
por: Wan, Shengli, et al.
Publicado: (2023)

Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation
por: Uchida, Mayako, et al.
Publicado: (2013)

In Vitro Biological Evaluation of Aprepitant Based (177)Lu-Radioconjugates
por: Halik, Paweł K., et al.
Publicado: (2022)

Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
por: Tian, Guixiang, et al.
Publicado: (2019)

Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE
por: Schottelius, Margret, et al.
Publicado: (2015)

Antitumor Effects of Curcumin and Glycyrrhetinic Acid-Modified Curcumin-Loaded Cationic Liposome by Intratumoral Administration
por: Chang, Mingxiang, et al.
Publicado: (2020)

Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits
por: Zhang, Xiuming, et al.
Publicado: (2019)

Predicting [(177)Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [(68)Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
por: Siebinga, Hinke, et al.
Publicado: (2023)

The Formation of Chitosan-Coated Rhamnolipid Liposomes Containing Curcumin: Stability and In Vitro Digestion
por: Zhou, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uul4sf1f2da9mvro3555nka17m